Longevity Vision Fund

General contacts

Investor type

PE / VC

Founded

2018

AUM

$100 M

Location

New York, New York, United States

Investment Ticket

$10-50 m

Investment Stage

Series A Seed Pre-seed Series B Late Stage (Series C+)

Region of investment

North America Europe Asia

Investor profile last updated: 16 August, 2026

Profile

Longevity Vision Fund is a venture capital firm based in New York, founded in 2019. The firm focuses on investing in technologies that aim to extend human lifespan and improve health. With a small team of professionals, they are dedicated to supporting breakthroughs in longevity and healthcare, distinguishing themselves by their commitment to making these advancements accessible and affordable.

The fund primarily invests in sectors such as preventive medicine, medical technologies, artificial intelligence in healthcare, longevity therapies, and regenerative medicine. They typically engage in Series A to C funding rounds, focusing on companies within the United States. Their portfolio includes investments in companies like Biolinq, Senda Biosciences, and Tessera Therapeutics. Longevity Vision Fund I, launched in 2020, manages assets worth $100 million.

Notable investments by Longevity Vision Fund include Biolinq - monitoring equipment, Senda Biosciences - biotechnology, Tessera Therapeutics - drug delivery, LyGenesis - drug discovery, and Eko - monitoring equipment. These companies reflect the fund's focus on innovative health technologies and longevity solutions.

Industry

HealthTech Pharmaceuticals Medical Devices Healthcare Services Life Sciences AI Biotechnology Infrastructure

Longevity Vision Fund Funds

Name	Type	Industry	Stage	Region	Size	AUM	Launch date
Longevity Vision Fund I	Venture Capital (VC)	Biotechnology Healthcare Services Medical Devices AI Infrastructure	Pre-seed Seed	North America	$5-10 m	$100 M	April 2020

Contacts

Name

Title

Social Networks

Sergey Young Founder

Founder

s•••@•••

Sourav Sinha Venture Partner & Head of Innovation

Venture Partner & Head of Innovation

s•••@•••

Upgrade to see contacts

6ATmYKc371F0Htol 6ATmYKc371F0Htol

6ATmYKc371F0Htol

[email protected]

6ATmYKc371F0Htol 6ATmYKc371F0Htol

6ATmYKc371F0Htol

[email protected]

6ATmYKc371F0Htol 6ATmYKc371F0Htol

6ATmYKc371F0Htol

[email protected]

Investment-team contacts for Longevity Vision Fund — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.

Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Longevity Vision Fund

Is Longevity Vision Fund a venture capital or private equity firm?

Longevity Vision Fund is a venture capital and private equity firm. It backs companies at Series A, Seed, Pre-seed, Series B and Late Stage (Series C+), writing tickets of $10-50 m.

Where is Longevity Vision Fund located?

Longevity Vision Fund is located in New York, New York, United States.

When was Longevity Vision Fund founded?

Longevity Vision Fund was founded in 2018.

What sectors and industries does Longevity Vision Fund invest in?

Longevity Vision Fund invests in companies and startups in HealthTech, Pharmaceuticals, Medical Devices, Healthcare Services, Life Sciences, AI, Biotechnology, Infrastructure.

What is Longevity Vision Fund geographical focus of investments?

Longevity Vision Fund invests in companies and startups in North America, Europe, Asia.

At what stages of companies and startups does Longevity Vision Fund typically invest in?

Longevity Vision Fund invests in companies and startups at Series A, Seed, Pre-seed, Series B, Late Stage (Series C+).

What is the usual amount of Longevity Vision Fund investment?

Longevity Vision Fund usually invests $10-50 m on average.

What is the amount of assets of under management (AUM) for Longevity Vision Fund?

Longevity Vision Fund has around $100m assets under management.

When was Longevity Vision Fund last fund created?

Longevity Vision Fund last fund was created/launched in 2020-04-27

What are the contacts of Longevity Vision Fund?

Longevity Vision Fund can be reached through its website longevity.vision and its LinkedIn page. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Longevity Vision Fund — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

Can I access Longevity Vision Fund data via API or MCP?

Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Longevity Vision Fund directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.

When was the Longevity Vision Fund profile last updated?

Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 16 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.